Intervention of Engineered Immune Effector T Cells Against Lung Cancer

NCT03353428 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped combine with NCT03356808

Conditions

Lung Cancer
NSCLC

Interventions

BIOLOGICAL: LC-CTLs

Sponsor

Shenzhen Geno-Immune Medical Institute